Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SUDEEPPHRM.NSthis companySudeep Pharma Ltd.	₹1,210.30	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
AARTIDRUGS.NSAarti Drugs Limited	₹499.75	14.97×	1.88×	1.14×	11.19×	-76.9%	29.2%	9.4%	7.6%	12.6%	10.1%	1.7%	0.37×	1.82×	7.19×	1.59×	0.6%	4	3.46	2	C
AARTIPHARM.NSAarti Pharmalabs Limited	₹921.40	32.96×	2.71×	3.16×	16.93×	-152.7%	54.1%	16.4%	9.6%	8.2%	7.3%	-3.2%	0.36×	1.94×	6.36×	1.49×	0.6%	6	4.24	3	B-
ALIVUS.NSAlivus Life Sciences Limited	₹1,474.40	21.18×	3.59×	4.69×	14.44×	-46.0%	44.6%	28.3%	22.1%	16.9%	15.6%	2.2%	0.02×	0.07×	134.39×	5.21×	0.5%	—	—	4	A-
INDSWFTLAB.NSInd-Swift Laboratories Limited	₹349.05	26.55×	0.79×	1.71×	15.31×	-42.2%	29.7%	2.3%	6.5%	3.0%	0.9%	-9.8%	0.01×	-9.08×	10.31×	3.8×	0.0%	2	7.26	3	B
IOLCP.NSIOL Chemicals and Pharmaceuticals Limited	₹202.95	15.52×	1.19×	0.92×	8.2×	-108.0%	21.7%	8.1%	5.9%	7.7%	6.9%	1.8%	0.08×	0.26×	12.97×	1.78×	1.4%	4	—	2	C
Peer median	—	21.18×	1.88×	1.71×	14.44×	-76.9%	29.7%	9.4%	7.6%	8.2%	7.3%	1.7%	0.08×	0.26×	10.31×	1.78×	0.6%	4	4.24	3	—